🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Oligometastatic Prostate Cancer

Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastatic Prostate Cancer NCT02971358NA1 site📍 Vienna Medical University of Vienna · Tests: Radical prostatectomy Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial NCT06563388Phase 31 site📍 Buffalo Roswell Park Cancer Institute · Tests: Stereotactic Ablative Radiotherapy, Best Practice Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer NCT07015138NA3 sites📍 Beijing📍 Beijing📍 Beijing Peking University First Hospital · Tests: TRT, NTRT Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT) NCT05404139Phase 22 sites📍 Toronto📍 Toronto University Health Network, Toronto · Tests: Abiraterone, Standard of Care SBRT and ADT, Atorvastatin 5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT) NCT04610372NA4 sites📍 Kelowna📍 Surrey📍 Vancouver British Columbia Cancer Agency · Tests: Hypofractionated external beam radiotherapy, High dose rate brachytherapy, Permanent seed implant, Stereotactic body ra… TERPS Trial for de Novo Oligometastic Prostate Cancer NCT05223803Phase 210 sites📍 La Jolla📍 Kansas City📍 Baltimore University of Maryland, Baltimore · Tests: Prostate radiation (XRT), Systemic Therapy, Stereotactic ablative radiation therapy (SABR) MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) NCT06150417Phase 23 sites📍 New York📍 Cleveland📍 Madison Case Comprehensive Cancer Center · Tests: Androgen deprivation therapy (ADT), Androgen receptor signaling inhibitor (ARSI), Local Therapy: Radical Prostatectomy … The Impact of Radiotherapy on Oligometastatic Cancer NCT05933876n/a21 sites📍 Albacete📍 Barcelona📍 Barcelona Institut Investigacio Sanitaria Pere Virgili · Tests: To propose a diagnostic test to determine the viability of Stereotactic ABlative Radiotherapy (SABR)., To propose a dia… Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy NCT05560659Phase 23 sites📍 St Leonards📍 Melbourne📍 Tel Aviv Peter MacCallum Cancer Centre, Australia · Tests: 177Lu-PSMA Prostate Radiotherapy and Metastasis-Directed Therapy in Synchronous Oligometastatic Prostate Cancer NCT07686016n/a1 site📍 Zamość Affidea Nu-med Center of Oncological DIagnostics and Therapy · Tests: Definitive Prostate-Directed Radiotherapy, Metastasis-Directed Stereotactic Body Radiotherapy, Pelvic Lymph Node Irradi… Neoadjuvant PSMA-RLT in Oligometastatic PCa NCT06259123Phase 21 site📍 Vienna Medical University of Vienna · Tests: [177Lu]Lu-PSMA I&T Maximal Tumor Eradication for Oligometastatic Prostate Cancer NCT06972511Phase 2, Phase 31 site📍 Shanghai RenJi Hospital · Tests: neoadjuvant apatamide plus ADT + radical resection of prostate cancer + extended lymph node dissection + radiotherapy o… MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02) NCT05183074NA1 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: MR-linac START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC NCT05209243NA2 sites📍 Madrid📍 Valencia Instituto de Investigación en Oncología Radioterápica - Fun… · Tests: SBRT, STANDARD OF CARE OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT) NCT06462963NA15 sites📍 Aalst📍 Brussels📍 Ghent European Organisation for Research and Treatment of Cancer … · Tests: single-fraction SBRT, multiple-fraction SBRT Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST) NCT05893381Phase 22 sites📍 Cesena📍 Meldola Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IR… · Tests: [177Lu]Lu-PSMA I&T, Stereotactic Radiotherapy Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical Prostatectomy and Staged as Oligometastatic With PSMA-PET NCT06758882Phase 21 site📍 Torino Marco Oderda · Tests: Apalutamide, Androgen receptor (AR) inhibitor JUR-003 in Adult Patients With Metastatic Prostate Cancer NCT07824349Phase 14 sites📍 Grand Rapids📍 Lake Success📍 Nashville Juri Biosciences, Inc. · Tests: JUR-003 Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART) NCT06546267n/a1 site📍 Milan IRCCS San Raffaele · Tests: Image Guided Radiotherapy, Intensity Modulated Radiotherapy, Stereotactic Body Radiotherapy Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC NCT07090148Phase 11 site📍 Madison University of Wisconsin, Madison · Tests: pTVG-HP DNA vaccine, Anti-PD-1 monoclonal antibody Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer NCT04983095NA7 sites📍 Lund📍 Stockholm📍 Stockholm Karin Soderkvist · Tests: stereotactic body radiotherapy, androgen deprivation therapy, Radiotherapy Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients. NCT07717268Phase 215 sites📍 Zaragoza📍 Barcelona📍 L'Hospitalet de Llobregat Instituto de Investigación en Oncología Radioterápica - Fun… · Tests: Xtandi, Zytiga® (Abiraterone Acetate), SBRT An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. NCT05939414Phase 3144 sites📍 Fayetteville📍 Los Angeles📍 Palo Alto Novartis Pharmaceuticals · Tests: AAA617, piflufolastat (18F), gallium (68Ga) gozetotide (25μg) Metastasis-directed Therapy for Oligorecurrent Prostate Cancer NCT05352178Phase 31 site📍 Leuven Universitaire Ziekenhuizen KU Leuven · Tests: Radiotherapy (SBRT) and/or surgery (metastasectomy), Androgen deprivation therapy, Androgen receptor targeted therapy The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC) NCT07038304Phase 22 sites📍 Groningen📍 Nijmegen University Medical Center Groningen · Tests: Metastasis directed radiotherapy Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer NCT06389786NA1 site📍 Jacksonville Mayo Clinic · Tests: Bilateral Pelvic Lymph Node Dissection, Biospecimen Collection, Bone Scan, Computed Tomography, Electronic Health Recor… OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed Oligometastatic Neoplasia of the Prostate NCT06273345n/a12 sites📍 Brixen📍 Abano Terme📍 Dolo Istituto Oncologico Veneto IRCCS Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer NCT05915442Phase 21 site📍 New York Catherine Spina · Tests: Quemliclustat, Etrumadenant, Zimberelimab, Stereotactic Body Radiation Therapy Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study NCT04175431Phase 22 sites📍 Pittsburgh📍 Seattle University of Washington · Tests: Positron Emission Tomography, Lymphadenectomy, Radiation Therapy, Abiraterone Acetate, Prednisone HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS) NCT06978296NA1 site📍 Saint-Herblain Institut Cancerologie de l'Ouest · Tests: Stereotactic body radiotherapy (SBRT)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy